One-pot coupling of a chiral selone derivatizing agent to a series of chiral and racemic amines mediated with triphosgene gives adducts in yields ranging from 80–99%; 77Se NMR spectroscopy evaluation of the diastereoisomeric adduct conveniently allows the determination of the enantiomeric excesses of the parent chiral amines.
The aldol reaction of acetate and methyl ketone-based donors with aldehyde acceptors is reviewed. Emphasis is placed on major advances reported in the last 10-15 years. Several methods for inducing chirality at the newly formed stereogenic center are discussed, including popular alternate methods for equivalent syntheses. Different methods for stereospecific synthesis are compared in terms of yield, selectivity, ease of synthesis, and applicability to both small molecule and large macrolide production.
Biosynthetic incorporation of selenium- and tellurium- containing amino acids has been exploited to produce both heavy-atom derivatives and nuclear magnetic resonance probes in biomacromolecules. These derivatives have played a significant role in the elucidation of both the local and global structures of a variety of biomacromolecules such as proteins and oligomeric nucleic acids. Although the replacement of methionine with selenomethionine (SeMet) in a protein was reported as early as 1957, it was not until recently that a seleniumcontaining amino acid was successfully used to simplify the phase problem of macromolecular crystallography through the use of multiwavelength anomalous diffraction (MAD) techniques. Boles and coworkers reported the first incorporation of telluromethionine (TeMet) into a protein. More recent research has included the incorporation of [4,5]selenatryptophan ([4,5]SeTrp) and [6,7]selenatryptophan ([6,7]SeTrp) into recombinant proteins, adding two additional tools to the arsenal of heavy-atom derivatives available to probe the structure and dynamics of biomacromolecules. Methods for the construction of Te / Se-Cys and Se-tyrosine and their potential use in biomolecular studies have been reported.
14 May 2012 in Journal of Labelled Compounds and Radiopharmaceuticals